Article Text

Cenesthetic hallucinations in a patient with Parkinson’s disease
  1. FÉLIX JAVIER JIMÉNEZ-JIMÉNEZ,
  2. MIGUEL ORTÍ-PAREJA,
  3. TERESA GASALLA,
  4. ANTONIO TALLÓN-BARRANCO,
  5. FRANCISCO CABRERA-VALDIVIA
  1. Department of Neurology
  2. Department of Psychiatry, Hospital Universitario “Príncipe de Asturias”, Alcalá de Henares, Madrid, Spain
  1. Dr Félix Javier Jiménez Jiménez, C/Corregidor José de Pasamonte, 24, 3º D, E-28030 Madrid, Spain.
  1. ALBERTO FERNÁNDEZ-LLIRIA
  1. Department of Neurology
  2. Department of Psychiatry, Hospital Universitario “Príncipe de Asturias”, Alcalá de Henares, Madrid, Spain
  1. Dr Félix Javier Jiménez Jiménez, C/Corregidor José de Pasamonte, 24, 3º D, E-28030 Madrid, Spain.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Hallucinations are a side effect of treatment with levodopa and dopamine agonists. They are more common in patients with Parkinson’s disease with advanced age and cognitive impairment.1-3Hallucinations secondary to dopaminergic drugs are usually visual, and less often, auditory.4 We describe a patient who developed cenesthetic hallucinations during pergolide and levodopa treatment.

A 66 year old woman with Parkinson’s disease, predominantly rigid akinetic, had been treated with carbidopa-levodopa since the age of 55 in 1984. When she was evaluated for the first time in our …

View Full Text